Ardelyx Inc (NASDAQ:ARDX) Stock Rockets 32% After The News

December 1, 2021

Specialty biopharmaceutical firm Ardelyx Inc (NASDAQ:ARDX) was in considerable focus among investors on Tuesday and it was apparent from the price action in the company’s stock. Trading Data On Tuesday, ARDX stock soared 32.24% at $1.14 with more than 43.42 million shares, compared to its average volume of 3.31 million shares. The stock has moved within a range of $0.8163 – 1.3100 after opening trade at $0.91.  Ardelyx Launching IBSRELA®…

Read More >>

Ardelyx Inc. (NASDAQ:ARDX) Stock On The Watchlist After The Recent News

September 7, 2021

Ardelyx Inc. (NASDAQ:ARDX) is in focus after announcing the publication of its long-term 52-week third phase PHREEDIM study in the American Society of Nephrology Journal, Kideny360.CEO and President Mike Raab said that the study assessed tenapanor monotherapy. It was the third of the three third phase studies conducted in the evaluation of tenapanor for serum phosphorous control in chronic kidney disease patients on dialysis. Mike said that the data from…

Read More >>